James Foran
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 195
- Acute Myeloid Leukemia Research 171
- Chronic Myeloid Leukemia Treatments 57
- Hematopoietic Stem Cell Transplantation 27
- Multiple Myeloma Research and Treatments 22
- Genetics 101
- Myeloproliferative Neoplasms: Diagnosis and Treatment 51
- Chronic Lymphocytic Leukemia Research 45
- Co-authors
- Ama Z. S. Rohatiner (14 shared papers)Richard Bell (1 shared paper)Mark C. Creamer (1 shared paper)Peter Johnson (9 shared papers)Bertrand Coiffier (6 shared papers)A. J. Norton (9 shared papers)Jörge E. Cortes (12 shared papers)Ivana N. Micallef (9 shared papers)
- Journals
- Blood (71 papers)Transplantation and Cellular Therapy (26 papers)American Journal of Hematology (23 papers)Blood Advances (22 papers)Journal of Clinical Oncology (14 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
James Foran
301 papers receiving 10.8k citations
James Foran's Hit Papers
Peers
Comparison fields: 5 of 145
- Hematology 5.3k
- Genetics 2.7k
- Pathology and Forensic Medicine 2.4k
- Oncology 2.6k
- Immunology 1.0k
Countries citing papers authored by James Foran
This map shows the geographic impact of James Foran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Foran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Foran more than expected).
Fields of papers citing papers by James Foran
This network shows the impact of papers produced by James Foran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Foran. The network helps show where James Foran may publish in the future.
Co-authors
The 25 scholars most cited alongside James Foran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 329 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML Hit paper breakdown → | 2018 | 1164 |
| 2 | Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2017 | 569 |
| 3 | 2000 | 398 | |
| 4 | Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 349 |
| 5 | Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study Hit paper breakdown → | 2014 | 324 |
| 6 | 2013 | 314 | |
| 7 | 1995 | 309 | |
| 8 | 2010 | 284 | |
| 9 | An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients. | 2003 | 273 |
| 10 | 2014 | 271 | |
| 11 | 2011 | 240 | |
| 12 | 2017 | 239 | |
| 13 | NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 Hit paper breakdown → | 2021 | 235 |
| 14 | 2018 | 179 | |
| 15 | 2000 | 173 | |
| 16 | 2021 | 166 | |
| 17 | 2021 | 146 | |
| 18 | 1999 | 142 | |
| 19 | 2020 | 138 | |
| 20 | 2013 | 134 |
About James Foran
James Foran is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 329 papers that have together received 11.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (171 papers), Chronic Myeloid Leukemia Treatments (57 papers), Lymphoma Diagnosis and Treatment (51 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (51 papers), Chronic Lymphocytic Leukemia Research (45 papers), Acute Lymphoblastic Leukemia research (42 papers), Hematopoietic Stem Cell Transplantation (27 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Hematology (5.3k citations), Genetics (2.7k citations), Pathology and Forensic Medicine (2.4k citations), Oncology (2.6k citations) and Immunology (1.0k citations). James Foran has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Ama Z. S. Rohatiner, Richard Bell, Mark C. Creamer, Peter Johnson, Bertrand Coiffier, A. J. Norton, Jörge E. Cortes, Ivana N. Micallef, T. Andrew Lister and Christian Gisselbrecht. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, American Journal of Hematology, Blood Advances and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.